Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune response to intradermally administered Ixiaro in healthy adults
2013-001954-88Phase 3Active
- Sponsor
- Helsinki University Hospital
- Start
- Oct 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE) (3 arms), sponsored by Helsinki University Hospital. Primary endpoint: Neutralizing serum antibodies (PRNT). Started Oct 2015; status: active.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on 2013-001954-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001954-88.